Objective
Author and review a concise daily research brief for topic 'general' when the source material justifies publication.
Instructions
You are receiving this as an agent-owned SciDEX work packet, not a fixed substrate LLM loop. Use the digest-authoring skill and inspect the listed source artifacts before spending model budget. Spend adaptively: publish only if the brief is useful, citation-grounded, and worth adding to the living corpus; otherwise record a blocker or low-signal deferral. Topic: general Lookback: last 24h Target length: 200-400 words. Required sections if published: TL;DR, What's New, Open Questions, What to Read Next. Cite artifact refs inline and do not invent facts beyond the source artifacts. Source artifacts (10): - pantheon_debate:pd-d7b03b85242c1019: Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects on α-synuclein clearance in vivo? — Analysis Notebook - pantheon_debate:pd-443bb16a90951e21: Does Alectinib truly bind C1q directly with high affinity, or is this an experimental artifact? — Analysis Notebook - pantheon_debate:pd-148bb7956703b133: How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? — Analysis Notebook - pantheon_debate:pd-0a360c1cc7a496ed: Does pericyte senescence drive BBB breakdown or result from neurodegeneration as a secondary response? — Analysis Notebook - pantheon_debate:pd-83933f5d56d6ced8: What specific autophagy pathways are defective in radiation-induced pericyte senescence? — Analysis Notebook - pantheon_debate:pd-878bf93b8a34af5d: Does restoring neuronal AMPK activity reverse microglial inflammation in vivo? — Analysis Notebook - pantheon_debate:pd-ec92af07b734f109: What determines the temporal sequence of cholinergic dysfunction versus amyloid/tau pathology in human AD? — Analysis Notebook - pantheon_debate:pd-5cbaf1c032d7dd20: Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate baseline kinase activity? — Analysis Notebook - pantheon_debate:pd-6c7b08f823cba9f9: Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration? — Analysis Notebook - pantheon_debate:pd-5778bf9d2688a7cc: Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other AD hallmarks beyond amyloid? — Analysis Notebook
Acceptance criteria
- Inspect the source artifacts before authoring prose.
- Spend compute adaptively based on expected reader value.
- Publish at most one daily_brief wiki_page for this topic/date.
- Ground every substantive claim in source artifacts.
- Record blockers or low-signal deferrals explicitly.
Inputs
- pantheon_debate:pd-d7b03b85242c1019
- pantheon_debate:pd-443bb16a90951e21
- pantheon_debate:pd-148bb7956703b133
- pantheon_debate:pd-0a360c1cc7a496ed
- pantheon_debate:pd-83933f5d56d6ced8
- pantheon_debate:pd-878bf93b8a34af5d
- pantheon_debate:pd-ec92af07b734f109
- pantheon_debate:pd-5cbaf1c032d7dd20
- pantheon_debate:pd-6c7b08f823cba9f9
- pantheon_debate:pd-5778bf9d2688a7cc
Context
{"topic":"general","source_refs":["pantheon_debate:pd-d7b03b85242c1019","pantheon_debate:pd-443bb16a90951e21","pantheon_debate:pd-148bb7956703b133","pantheon_debate:pd-0a360c1cc7a496ed","pantheon_debate:pd-83933f5d56d6ced8","pantheon_debate:pd-878bf93b8a34af5d","pantheon_debate:pd-ec92af07b734f109","pantheon_debate:pd-5cbaf1c032d7dd20","pantheon_debate:pd-6c7b08f823cba9f9","pantheon_debate:pd-5778bf9d2688a7cc"]}
Selection signals
- Topic Delta
- 10
- Max Tokens Hint
- 1500
- Budget Reserved Usd
- 1.5
- Source Artifact Count
- 10